Checkpoint Capital L.P. Quant / Systematic

CIK: 0001977548 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 14, 2024

Total Value ($000): $165,881 (100.0% shares, 0.0% debt)

Holdings (16)

RYTM RHYTHM PHARMACEUTICALS INC 22.8%

Value ($000) $37,861 Shares 922,100 Est. Cost $33.69 Unrealized +18.5%

ARGX ARGENX SE 21.3%

Value ($000) $35,328 Shares 82,150 Est. Cost $382.37 Unrealized —

AXSM AXSOME THERAPEUTICS INC 14.1%

Value ($000) $23,407 Shares 290,772 Est. Cost $70.77 Unrealized +4.6%

— AVADEL PHARMACEUTICALS PLC 9.6%

Value ($000) $16,003 Shares 1,138,178 Est. Cost $14.06 Unrealized —

PTGX PROTAGONIST THERAPEUTICS INC 7.4%

Value ($000) $12,301 Shares 355,000 Est. Cost $20.35 Unrealized +44.0%

CYTK CYTOKINETICS INC 6.2%

Value ($000) $10,294 Shares 190,000 Est. Cost $36.21 Unrealized +66.7%

PHAT PHATHOM PHARMACEUTICALS INC 5.4%

Value ($000) $9,013 Shares 875,000 Est. Cost $9.43 Unrealized +9.2%

CORT CORCEPT THERAPEUTICS INC 4.8%

Value ($000) $7,952 Shares 244,750 Est. Cost $23.63 Unrealized +15.9%

ATYR ATYR PHARMA INC 1.8%

Value ($000) $3,037 Shares 1,946,477 Est. Cost $1.40 Unrealized +24.3%

PLRX PLIANT THERAPEUTICS INC 1.5%

Value ($000) $2,496 Shares 232,200 Est. Cost $12.89 Unrealized 0.0%

KYMR KYMERA THERAPEUTICS INC 1.5%

Value ($000) $2,448 Shares 82,000 Est. Cost $34.62 Unrealized 0.0%

— CIDARA THERAPEUTICS INC 1.0%

Value ($000) $1,736 Shares 145,417 Est. Cost $11.94 Unrealized —

TRVI TREVI THERAPEUTICS INC 0.9%

Value ($000) $1,490 Shares 500,089 Est. Cost $1.51 Unrealized +83.5%

— APPLIED THERAPEUTICS INC 0.6%

Value ($000) $1,062 Shares 227,470 Est. Cost $6.73 Unrealized —

SLNO SOLENO THERAPEUTICS INC 0.5%

Value ($000) $804 Shares 19,695 Est. Cost $42.38 Unrealized 0.0%

— ALLAKOS INC 0.4%

Value ($000) $650 Shares 649,957 Est. Cost $2.11 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
RYTM	RHYTHM PHARMACEUTICALS INC	922,100	$37,861	22.8%	$33.69	+18.5%	COM	76243J105
ARGX	ARGENX SE	82,150	$35,328	21.3%	$382.37	—	SPONSORED ADR	04016X101
AXSM	AXSOME THERAPEUTICS INC	290,772	$23,407	14.1%	$70.77	+4.6%	COM	05464T104
—	AVADEL PHARMACEUTICALS PLC	1,138,178	$16,003	9.6%	$14.06	—	COM SHS	G29687103
PTGX	PROTAGONIST THERAPEUTICS INC	355,000	$12,301	7.4%	$20.35	+44.0%	COM	74366E102
CYTK	CYTOKINETICS INC	190,000	$10,294	6.2%	$36.21	+66.7%	COM NEW	23282W605
PHAT	PHATHOM PHARMACEUTICALS INC	875,000	$9,013	5.4%	$9.43	+9.2%	COM	71722W107
CORT	CORCEPT THERAPEUTICS INC	244,750	$7,952	4.8%	$23.63	+15.9%	COM	218352102
ATYR	ATYR PHARMA INC	1,946,477	$3,037	1.8%	$1.40	+24.3%	COM NEW	002120202
PLRX	PLIANT THERAPEUTICS INC	232,200	$2,496	1.5%	$12.89	0.0%	COM	729139105
KYMR	KYMERA THERAPEUTICS INC	82,000	$2,448	1.5%	$34.62	0.0%	COM	501575104
—	CIDARA THERAPEUTICS INC	145,417	$1,736	1.0%	$11.94	—	COM NEW	171757206
TRVI	TREVI THERAPEUTICS INC	500,089	$1,490	0.9%	$1.51	+83.5%	COM	89532M101
—	APPLIED THERAPEUTICS INC	227,470	$1,062	0.6%	$6.73	—	COM	03828A101
SLNO	SOLENO THERAPEUTICS INC	19,695	$804	0.5%	$42.38	0.0%	COM	834203309
—	ALLAKOS INC	649,957	$650	0.4%	$2.11	—	COM	01671P100